Frank Schaefer

Title: Frank Schaefer: Innovator in Pharmaceutical Processes

Introduction

Frank Schaefer is a notable inventor based in Rheinfelden, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for manufacturing complex chemical compounds. With a total of 2 patents to his name, Schaefer continues to push the boundaries of innovation in his industry.

Latest Patents

Schaefer's latest patents include a process for manufacturing 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine. This invention discloses improved methods for producing this compound, its monohydrochloride salt, and the intermediates involved in the process. Another significant patent is for the preparation of N-substituted 2-cyanopyrrolidines, which relates to a process for creating N-(N'-substituted glycyl)--cyanopyrrolidine.

Career Highlights

Frank Schaefer is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions that address complex pharmaceutical challenges. His expertise in chemical processes has made him a valuable asset to the company.

Collaborations

Schaefer has collaborated with talented coworkers such as Rasmus Mose and Nicole Bieri. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.

Conclusion

Frank Schaefer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to advancing chemical processes. His work continues to impact the field positively.